1. Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi. (15th December 2020) Authors: Hsieh, Yuli L.; Jahn, Andreas; Menzies, Nicolas A.; Yaesoubi, Reza; Salomon, Joshua A.; Girma, Belaineh; Gunde, Laurence; Eaton, Jeffrey W.; Auld, Andrew; Odo, Michael; Kiyiika, Caroline N.; Kalua, Thokozani; Chiwandira, Brown; Mpunga, James U.; Mbendra, Kuzani; Corbett, Liz; Hosseinipour, Mina C... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 85:Number 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study. Issue 5 (May 2022) Authors: Nabity, Scott A; Mponda, Kelvin; Gutreuter, Steve; Surie, Diya; Zimba, Suzgo B; Chisuwo, Laphiod; Moffitt, Allison; Williams, Anne M; Sharma, Andrea J; Marshall, Rebekah E; Chiwaula, Mabvuto J; da Silva, Robin; Kumwenda, Tapiwa; Chilikutali, Lloyd; Mwamale, Shallom; Nagoli, Esther; Mwenyeheri, Ge... Journal: Lancet Issue: Volume 10:Issue 5(2022) Page Start: e705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗